This marked acceleration of tumor onset and progression appears to result from the unique activation of β-catenin signaling in lymphoma cells from Lck-Dlx5;Lck-MyrAkt2 mice, as activation of Akt, Notch, and Myc were common to the lymphomas from mice with all three genotypes. The gene discussed is DLX5; the disease is neoplasm.